Header cover image

Indonesian (IDX) Pharma Industry Analysis

UpdatedApr 25, 2024
DataAggregated Company Financials
Companies8
  • 7D-3.2%
  • 3M-10.3%
  • 1Y-26.5%
  • YTD-13.5%

Over the last 7 days, the Pharma industry has dropped 5.4%, driven by a pullback from Kalbe Farma of 1.7%. Overall the industry is down 26% in 12 months. As for the next few years, earnings are expected to grow by 11% per annum.

Industry Valuation and Performance

Has the Indonesian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 25 Apr 2024Rp89.0tRp66.6tRp4.4t14x20.3x1.3x
Sat, 23 Mar 2024Rp93.7tRp65.9tRp4.7t18.6x19.9x1.4x
Mon, 19 Feb 2024Rp93.6tRp65.9tRp4.7t18.6x19.7x1.4x
Wed, 17 Jan 2024Rp99.5tRp65.9tRp4.7t17.6x21x1.5x
Fri, 15 Dec 2023Rp98.6tRp65.9tRp4.7t18.7x20.8x1.5x
Sun, 12 Nov 2023Rp98.1tRp66.2tRp5.3t19.9x18.6x1.5x
Tue, 10 Oct 2023Rp107.1tRp65.6tRp5.4t21.9x19.8x1.6x
Thu, 07 Sep 2023Rp104.5tRp65.6tRp5.4t21.1x19.4x1.6x
Sat, 05 Aug 2023Rp111.3tRp64.4tRp5.3t22.7x20.9x1.7x
Mon, 03 Jul 2023Rp118.1tRp64.2tRp5.3t20.7x22.2x1.8x
Wed, 31 May 2023Rp117.9tRp64.2tRp5.3t21.3x22.2x1.8x
Fri, 28 Apr 2023Rp123.5tRp64.2tRp4.8t14.7x25.8x1.9x
Sun, 26 Mar 2023Rp124.0tRp65.0tRp4.6t20.3x26.8x1.9x
Tue, 21 Feb 2023Rp133.4tRp65.0tRp4.6t21.3x28.9x2.1x
Thu, 19 Jan 2023Rp124.2tRp65.0tRp4.6t22.1x26.9x1.9x
Sat, 17 Dec 2022Rp126.7tRp65.0tRp4.6t22.3x27.4x1.9x
Mon, 14 Nov 2022Rp121.3tRp65.4tRp4.7t15.2x25.8x1.9x
Wed, 12 Oct 2022Rp114.6tRp66.0tRp4.9t20.5x23.6x1.7x
Fri, 09 Sep 2022Rp108.2tRp67.1tRp5.1t19.6x21.2x1.6x
Sun, 07 Aug 2022Rp105.0tRp67.2tRp5.2t14.8x20x1.6x
Tue, 05 Jul 2022Rp106.6tRp66.7tRp5.2t14.4x20.4x1.6x
Thu, 02 Jun 2022Rp110.7tRp66.2tRp5.2t21.8x21.3x1.7x
Sat, 30 Apr 2022Rp109.5tRp64.8tRp5.1t21.8x21.3x1.7x
Mon, 28 Mar 2022Rp114.4tRp63.2tRp5.1t24.3x22.3x1.8x
Wed, 23 Feb 2022Rp116.0tRp63.2tRp5.1t24.5x22.7x1.8x
Fri, 21 Jan 2022Rp118.9tRp63.2tRp5.1t24.6x23.2x1.9x
Sun, 19 Dec 2021Rp118.0tRp63.1tRp5.1t24.7x23x1.9x
Tue, 16 Nov 2021Rp114.7tRp60.3tRp4.4t25x25.8x1.9x
Thu, 14 Oct 2021Rp106.4tRp58.5tRp4.3t21.1x24.9x1.8x
Sat, 11 Sep 2021Rp107.9tRp57.5tRp4.3t23.1x25.4x1.9x
Mon, 09 Aug 2021Rp98.1tRp57.5tRp4.3t20.4x23.1x1.7x
Sun, 02 May 2021Rp108.5tRp56.1tRp4.1t24.3x26.2x1.9x
Price to Earnings Ratio

26.2x


Total Market Cap: Rp108.5tTotal Earnings: Rp4.1tTotal Revenue: Rp56.1tTotal Market Cap vs Earnings and Revenue0%0%0%
Indonesian Pharma Industry Price to Earnings3Y Average 23x202220232024
Current Industry PE
  • Investors are pessimistic on the Indonesian Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 20.0x which is lower than its 3-year average PE of 23.0x.
  • The 3-year average PS ratio of 1.8x is higher than the industry's current PS ratio of 1.3x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have remained mostly flat over the last three years.
  • Meanwhile revenues for these companies have grown 5.9% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.

Industry Trends

Which industries have driven the changes within the Indonesian Healthcare industry?

ID Market0.89%
Healthcare-0.95%
Pharma-3.23%
Pharma-3.23%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
TSPC Tempo Scan PacificRp1.93k0.3%
+Rp22.5b		37.5%PE7.4x
MERK MerckRp4.01k0.3%
+Rp4.5b		-17.8%PE11.2x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

PYFA

Rp162.00

Pyridam Farma

7D

-79.1%

1Y

-81.3%

INAF

Rp135.00

Indofarma

7D

-37.5%

1Y

-80.3%

PEHA

Rp498.00

Phapros

7D

-0.4%

1Y

-26.8%

KLBF

Rp1,405.00

Kalbe Farma

7D

-3.4%

1Y

-32.5%

TSPC

Rp1,925.00

Tempo Scan Pacific

7D

0.3%

1Y

37.5%

DVLA

Rp1,415.00

Darya-Varia Laboratoria

7D

-4.4%

1Y

-28.4%

MERK

Rp4,010.00

Merck

7D

0.3%

1Y

-17.8%

KAEF

Rp755.00

Kimia Farma

7D

-5.0%

1Y

-16.6%